Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:CAR_T-cell_therapy
|
| gptkbp:clinical_trial |
gptkb:2020
Phase 1 |
| gptkbp:developed_by |
gptkb:TCR2_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
TCR-001
|
| gptkbp:indication |
gptkb:Oncology
|
| gptkbp:mechanism_of_action |
T-cell activation
|
| gptkbp:route_of_administration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:targets |
gptkb:NY-ESO-1
|
| gptkbp:treatment |
gptkb:immunotherapy
|
| gptkbp:bfsParent |
gptkb:Athenex_Oncology
|
| gptkbp:bfsLayer |
7
|